Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First case of Mycobacterium longobardum infection.
Hong SK, Sung JY, Lee HJ, Oh MD, Park SS, Kim EC. Hong SK, et al. Among authors: oh md. Ann Lab Med. 2013 Sep;33(5):356-9. doi: 10.3343/alm.2013.33.5.356. Epub 2013 Aug 8. Ann Lab Med. 2013. PMID: 24003427 Free PMC article.
Blood culture-free ultra-rapid antimicrobial susceptibility testing.
Kim TH, Kang J, Jang H, Joo H, Lee GY, Kim H, Cho U, Bang H, Jang J, Han S, Kim DY, Lee CM, Kang CK, Choe PG, Kim NJ, Oh MD, Kim TS, Kim I, Park WB, Kwon S. Kim TH, et al. Among authors: oh md. Nature. 2024 Aug;632(8026):893-902. doi: 10.1038/s41586-024-07725-1. Epub 2024 Jul 24. Nature. 2024. PMID: 39048820
Limited impact of bacterial virulence on early mortality risk factors in Acinetobacter baumannii bacteremia observed in a Galleria mellonella model.
Ham SY, Chun JY, Song KH, Kang CK, Park JS, Jo HB, Ryu CM, Choi Y, Choi SJ, Lee E, Choe PG, Moon SM, Park WB, Bang J, Park SW, Park KU, Kim NJ, Oh MD, Kim ES, Kim HB. Ham SY, et al. Among authors: oh md. Sci Rep. 2024 Jun 28;14(1):14960. doi: 10.1038/s41598-024-65940-2. Sci Rep. 2024. PMID: 38942780 Free PMC article.
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Clifford Lane H, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Sep 23;230(3):624-634. doi: 10.1093/infdis/jiae198. J Infect Dis. 2024. PMID: 38657001 Free PMC article. Clinical Trial.
356 results